T-CELL RECEPTOR EXCISION CIRCLES LEVELS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION ARE CORRELATED WITH RELAPSE IN PATIENTS WITH AML AND MDS

被引：0
|
作者：
Uhlin, M.
Sairafi, D.
Mattsson, J.
Uzunel, M.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-AB276
引用
收藏
页码：S556 / S556
页数：1
相关论文
共 50 条
  • [21] Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant
    Broglie, Larisa
    Helenowski, Irene
    Jennings, Lawrence J.
    Schafernak, Kristian
    Duerst, Reggie
    Schneiderman, Jennifer
    Tse, William
    Kletzel, Morris
    Chaudhury, Sonali
    PEDIATRIC BLOOD & CANCER, 2017, 64 (09)
  • [22] The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
    Li, Zhipeng
    Wang, Jing
    Deng, Lei
    Liu, Ximin
    Kong, Fanjun
    Zhao, Yuerong
    Hou, Yixi
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [24] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [25] Flow cytometry analysis, T-cell receptor excision circles (TREC) and κ-deleting recombination circles (KREC) quantification for immune reconstitution assessment after allogeneic cell transplantation
    Waterhouse, Miguel
    Bartsch, Ingrid
    Pfeifer, Dietmar
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    BONE MARROW TRANSPLANTATION, 2019, 54 : 487 - 488
  • [26] Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Xu Guo-Fa
    Chen Ting
    Liu Huanfeng
    Lin Shijia
    Lei Gao
    Cheng Zhang
    Yao Liu
    Xi Zhang
    Zeng, Defu
    Kong Peiyan
    BLOOD, 2018, 132
  • [27] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Giagounidis, A.
    Zohren, F.
    Bruns, I.
    Wolschke, C.
    Rieger, K.
    Fenk, R.
    Germing, U.
    Haas, R.
    Kroeger, N.
    Kobbe, G.
    LEUKEMIA, 2013, 27 (06) : 1229 - 1235
  • [28] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    Pollyea, D. A.
    Artz, A. S.
    Stock, W.
    Daugherty, C.
    Godley, L.
    Odenike, O. M.
    Rich, E.
    Smith, S. M.
    Zimmerman, T.
    Zhang, Y.
    Huo, D.
    Larson, R.
    van Besien, K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1027 - 1032
  • [29] Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
    T Schroeder
    A Czibere
    U Platzbecker
    G Bug
    L Uharek
    T Luft
    A Giagounidis
    F Zohren
    I Bruns
    C Wolschke
    K Rieger
    R Fenk
    U Germing
    R Haas
    N Kröger
    G Kobbe
    Leukemia, 2013, 27 : 1229 - 1235
  • [30] Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    D A Pollyea
    A S Artz
    W Stock
    C Daugherty
    L Godley
    O M Odenike
    E Rich
    S M Smith
    T Zimmerman
    Y Zhang
    D Huo
    R Larson
    K van Besien
    Bone Marrow Transplantation, 2007, 40 : 1027 - 1032
12345